NCT05610514

Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: University of Vermont · Academic / Other
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the effects of e-cigarettes and continued smoking on pulmonary and cardiac outcomes in a population with established pulmonary disease.

Detailed description

E-cigarettes with nicotine can affect important cardiopulmonary outcomes and likely pose less risk than cigarettes, but they are not harmless. Given the existing literature, there is a need for controlled trials of e-cigarette use in populations with cardiopulmonary disease to fill the gaps between these existing examinations. Clarifying how the pulmonary and cardiac effects of e-cigarettes compare to use of conventional cigarettes in those with cardiopulmonary disease beyond single acute exposures will provide important new health information that can help inform policy.

Conditions

• Chronic Obstructive Pulmonary Disease
• Chronic Bronchitis
• Emphysema
• Asthma-COPD Overlap Syndrome

Interventions

Type	Name	Description
OTHER	E-Cigarette	Altering the availability of e-cigarettes
BEHAVIORAL	Financial Incentives	Altering the availability of financial incentives for abstaining from combustible cigarettes

Timeline

• Start date: 2022-04-28
• Primary completion: 2023-12-01
• Completion: 2023-12-01
• First posted: 2022-11-09
• Last updated: 2024-02-08

Locations

1 site across 1 country: United States